Format

Send to

Choose Destination
See comment in PubMed Commons below
Eur Radiol. 2015 Nov;25(11):3161-6. doi: 10.1007/s00330-015-3749-5. Epub 2015 Apr 22.

Hyperintense acute reperfusion marker is associated with higher contrast agent dosage in acute ischaemic stroke.

Author information

1
Academic Neuroradiology, Center for Stroke Research Berlin (CSB), Charité Universitätsmedizin Berlin, Hindenburgdamm 30, 12203, Berlin, Germany. aostwaldt@mgh.harvard.edu.
2
Academic Neuroradiology, Center for Stroke Research Berlin (CSB), Charité Universitätsmedizin Berlin, Hindenburgdamm 30, 12203, Berlin, Germany.
3
Department of Neurology, Charité Universitätsmedizin, Charitéplatz 1, 10117, Berlin, Germany.
4
Jüdisches Krankenhaus Berlin, Stiftung des Bürgerlichen Rechts, Heinz-Galinski-Straße 1, 13347, Berlin, Germany.

Abstract

OBJECTIVE:

The hyperintense acute reperfusion marker (HARM) on fluid-attenuated inversion recovery (FLAIR) images is associated with blood-brain barrier (BBB) permeability changes. The aim of this study was to examine the influence of contrast agent dosage on HARM incidence in acute ischaemic stroke patients.

METHODS:

We prospectively included 529 acute ischaemic stroke patients (204 females, median age 71 years). Patients underwent a first stroke-MRI within 24 hours from symptom onset and had a follow-up on day 2. The contrast agent Gadobutrol was administered to the patients for perfusion imaging or MR angiography. The total dosage was calculated as ml/kg body weight and ranged between 0.04 and 0.31 mmol/kg on the first examination. The incidence of HARM was evaluated on day 2 FLAIR images.

RESULTS:

HARM was detected in 97 patients (18.3%). HARM incidence increased significantly with increasing dosages of Gadobutrol. Also, HARM positive patients were significantly older. HARM was not an independent predictor of worse clinical outcome, and we did not find an association with increase risk of haemorrhagic transformation.

CONCLUSIONS:

A higher dosage of Gadobutrol in acute stroke patients on initial MRI is associated with increased HARM incidence on follow-up. MRI studies on BBB should therefore standardize contrast agent dosages.

KEY POINTS:

• Hyperintense acute reperfusion marker on MRI indicates blood-brain barrier disruption. • This observational study on stroke patients characterizes HARM. • Incidence depends on contrast agent dosage on the previous day. • HARM is also associated with older age and poor kidney function. • Interpretation of HARM must take dosage into consideration.

KEYWORDS:

Acute stroke; Blood-Brain Barrier; Dosage; Gadolinium; Magnetic Resonance Imaging

PMID:
25899419
DOI:
10.1007/s00330-015-3749-5
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Springer
    Loading ...
    Support Center